GeneNews Seeks to Raise $2.6M in Rights Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews announced after the close of the market on Wednesday a rights offering intended to raise about C$2.5 million (US$2.6 million).

Proceeds from the offering will go toward commercialization of the Toronto-based molecular diagnostics firm's ColonSentry test, a blood-based colon cancer risk stratification test, and for general corporate and administrative expenses, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.